Search
for
Sort by
Research 31–60 of 1000+
- Male-pattern baldness susceptibility locus at 20p11
- Losing Hair, Losing Points?: The Effects of Male Pattern Baldness on Social Impression Formation1
- The effect of finasteride, a 5 alpha-reductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldness.
- Dose-response study of topical minoxidil in male pattern baldness
- GWAS for male-pattern baldness identifies 71 susceptibility loci explaining 38% of the risk
- Topical minoxidil in male pattern baldness: Effects of discontinuation of treatment
- Association of Benign Prostatic Hyperplasia with Male Pattern Baldness
- Use of topical minoxidil in the treatment of male pattern baldness
- Serum elevation of dehydroepiandrosterone sulfate associated with male pattern baldness in young men
- Susceptibility variants on chromosome 7p21.1 suggest HDAC9 as a new candidate gene for male-pattern baldness
- Increased Androgen Binding Capacity in Sebaceous Glands in Scalp of Male-pattern Baldness
- Long-term follow-up of men with male pattern baldness treated with topical minoxidil
- Treatment of Male Pattern Baldness with Botulinum Toxin: A Pilot Study
- Evaluation of DNA Variants Associated with Androgenetic Alopecia and Their Potential to Predict Male Pattern Baldness
- Biochemical Roles of Testosterone and Epitestosterone to 5α-Reductase as Indicators of Male-Pattern Baldness
- Long-term efficacy of topical minoxidil in male pattern baldness
- Male pattern baldness: current treatments, future prospects
- Investigation of the male pattern baldness major genetic susceptibility loci AR/EDA2R and 20p11 in female pattern hair loss
- Male pattern baldness and the risk of prostate cancer
- Letter: Platelet-Rich Plasma for Treating Male Pattern Baldness
- <i>Curcuma aeruginosa</i>, a novel botanically derived 5α-reductase inhibitor in the treatment of male-pattern baldness: a multicenter, randomized, double-blind, placebo-controlled study
- Quantitative assessment of 2% topical minoxidil in the treatment of male pattern baldness
- Postscreening follow-up of the Finnish Prostate Cancer Screening Trial on putative prostate cancer risk factors: vitamin and mineral use, male pattern baldness, pubertal development and non-steroidal anti-inflammatory drug use
- Differential expression analysis of balding and nonbalding dermal papilla microRNAs in male pattern baldness with a microRNA amplification profiling method
- Male pattern baldness and prostate cancer risk in a population-based case–control study
- Relationship Between Male Pattern Baldness and the Risk of Aggressive Prostate Cancer: An Analysis of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
- 2% Topical Minoxidil Solution in Male-Pattern Baldness: Preliminary European Results
- Evaluation of androgens in the scalp hair and plasma of patients with male-pattern baldness before and after finasteride administration
- Review: Topical Minoxidil for Male Pattern Baldness
- A pilot study on the sexual side effects of finasteride as related to hand preference for men undergoing treatment of male pattern baldness